Concepedia

Shenmiao Yang

SY

Statistics

Publications

15

Citations

454

H-Index

13

Active since

2015

Affiliations

Peking University(Current)

Peking University People's Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Jiangsu Province Hospital

Tongji Hospital

Shenmiao Yang is an author at Peking University specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2015–2023

15

Publications

15

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 128 citations · Full text

Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study

Ningjing Lin, Mingzhi Zhang, Hai Bai et al. · European Journal of Cancer · 2021 · 47 citations · Full text

Ethnic and geographic diversity of chronic lymphocytic leukaemia

Shenmiao Yang, Abraham Varghese, Nitin Sood et al. · Leukemia · 2020 · 45 citations

, , +8

Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study

Wei Xu, Keshu Zhou, Tingyu Wang et al. · American Journal of Hematology · 2023 · 34 citations · Full text

ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation

Jiamin Zhang, Chen‐Cong Wang, Gao‐Chao Zhang et al. · Cancer Letters · 2018 · 33 citations

, , +12

1–5 of 15